Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Nope. This is ridiculous. The market will continue to walk away from this.
Selling now, but watch NYC they need a heath pass just to eat at a restaurant.
Big solutions... CLX HA. Download the app when ready.
How low can this go? Subpenny?
When will chas start dumping his free shares?
Is the hype over? Did those helicopters ever land after the hurricane?
Big week! Let’s see if the OTC likes preferred share dividends.
Nader is a rookie, no doubt, but MaBs are just too new and threatening to the status quo.
Israel needs LL badly but I seriously doubt they’ll go against Gilead.
If we see HGEN get a EUA then NPs Covid failure is complete.
At least most pennies can generate a fraudulent pump... CTDT can’t even do that.
Saunders may just be the forever optimist.
Some shareholders have made personal visits to see Chas and co... I won’t spend good money chasing bad for someone who can’t pick up the phone.
Vaccines slowing down....
Is FDA aware of Leronlimab? Lol.
It’s just too new for those guys. Only person working at warp speed is Bruce Patterson...
Hmmm... I hope so... NP drags it down and then boom UK has no choice to approve.
Volatility is a traders friend
News isn’t mainstream... red markets. Best is yet to come here
Take away his hype and it would be a lot worse. So he hasn’t failed but he sure hasn’t met his lofty predictions.
Could be a moot point. USA is bridging a timeline with Rem to the vaccine and possibly “skipping” any window for MAB therapeutics.
NP isn’t being honest only because he needs to keep the SP up.
That’s trending...
They’ll get to the BoD and offer attractive reasons why they should sell.
He shouldn’t have to, the company is still paying rent to the Snaper family... where does that money come from?
If they are serious then sell the current building they own and use that as a down payment on the new place.
Agreed, not many caught that. I think the $15 for preferred is way under priced but hey... underpromise - overdeliver right?
Good PR, but it’s still just hope. Ride the wave
Big money waiting on the RM final. Can’t jump out ahead of it.
Today’s PR was a big boost in confidence. Keeps attention on it until 9/18, plus reduces the float.
Love a divvy to force short covering. Come on 9/18...
How much longer after 9/18 until the deal is done? October looking good.
When is the move to the OZ?
Converting common to preferred will reduce the float... will it not? Removing a rate of 250:1. Wow.
If those answers were known you’d see volume here. No one can answer that yet.
FDA expanding EUA for remdesivir...
CYDY better realize the FDA won’t let them in the party.
Pretty sad that AMERICANs die while the Fauci cuddles with Gilead.
He’s definitely not Capable. He keeps telling Proactive he should be fired if he’s not doing a good job. Awkward silence....
Leronlimab is waiting .... the world is waiting...
Where’s the science? Lol. Oh the science of lobbying... thanks for clarifying.
Many thanks to DrBP for exposing the truth of Covid MOA. Hence exposing the FDA misguided actions and bias for Gilead. How many died because of the bias?
$10 minimum is the fair value. It’s at $3 due to the poor optics and shorts taking advantage of NP history and actions.
Without FDA approval that’s how fragile this SP is... a fart turns into a diaper blowout.
Good, now can we the shareholders file a class action suit against EMA to reclaim the lost equity due to their fraudulent activities?
EMA owes me $80k at least. Assholes. I’ll take payments for life.
New Dr Drew tweet out crediting DrBPatt for CCL5 pathway of Covid.
Also noted that he said drug companies are now playing catch-up to CYDY.
Trust no one... only items that are true are ones that can be independently verified.
If the BOD maintains current course? Likely, Yes.
NIH/OWS... shout M2M data from the mountain tops.
Indeed. Free media is “costing” cydy equity right now.
Paying Proactive to ask NP prepared softball questions that he doesn’t answer well isn’t helping either. Lol.
NP Just stop... please just stop. Focus on the data and actions....
Cydy is desperate for media attention. What happened to the supposedly hired media director?
Stop desperately seeking shill reporters and this Hack journalism will stop. If a reporter were to call me I’d just refer them to the P2 M2M data and they can get an interview when the approval is granted.
Require final review rights and signoff before publication.
This isn’t hard stuff to manage...
Yes, but the management and optics suck so SP suffers.
There’s a reason why companies typically don’t get out of the OTC. It’s playing out here right now....
Starting to look like incompetence more every day.
She’s not aware of the P2 M2M trial results?
Maybe NP didn’t send it to them?
That seems to be the trend. Maybe we’ll need to fly to the UK for treatment soon?
I’d like to know how many countries have called NP asking for access to leronlimab. His response... “We are waiting on FDA”.
Looks like AMERICAN airlines would like to see leronlimab approved. 19,000 laid off in October?
Tick Tock FDA.... EUA? Lol... come on ... BS useless drugs get EUAs but working drugs don’t?
Looks this deal will done under the radar catching the OTC off guard at a nickel.
They are moving fast....
The SOC in the UK might be much worse than the USA. Also the News2 maybe carrying a lot of weight with UK doctors.
Many here have been telling NP to go global.... now that they have things are moving.